Requires that pharmacists get express written consent before substituting a drug product for a less expensive drug product, including biological products.
- Chamber
- House
- Introduced
- Feb 6, 2025
- Last action
- Jan 7, 2026 — REFERRED TO HIGHER EDUCATION
- Session
- 2025-2026
- Momentum
- 27 · Low